Rossi Christina's Form 4 filing
Blueprint Medicines Corp (BPMC) · filed Jan 23, 2025
- Accession no.
- 0001415889-25-001991
- Filed
- Jan 23, 2025
- Trade date
- Jan 21, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $250.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rossi ChristinaCIK 0001756941 | Officer (CHIEF OPERATING OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 21, 2025 | Common Stock | SSaleDisposed | −529 | $108.99 | −$57,655.71 | 68,854 | Direct | |
| Jan 21, 2025 | Common Stock | SSaleDisposed | −816 | $110.00 | −$89,760 | 68,038 | Direct | |
| Jan 21, 2025 | Common Stock | SSaleDisposed | −808 | $110.78 | −$89,510.24 | 67,230 | Direct | |
| Jan 21, 2025 | Common Stock | SSaleDisposed | −121 | $111.81 | −$13,529.01 | 67,109 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.